NCT03152604

Brief Summary

Persistent pain (PP) affects many people worldwide. Patient Education is central to good management. Pain neurophysiology education (PNE) is a new form of education. It aims to help patients 'reconceptualise' their understanding of pain away from the perception that PP is an indicator of tissue damage, to PP is due to a sensitised nervous system. This perception is considered a less threatening and more conducive to rehabilitation. There is a growing body of evidence supporting its effectiveness. One unpublished Australian study combined PNE with a pain management program and found significant beneficial effects. However, there is a need to test this intervention rigorously under randomised controlled trial conditions to inform clinical practice. The Medical Research Council state that during the development and evaluation of a complex intervention (in this case a PNE informed PMP), it is important to undertake feasibility work, to investigate the components of randomised controlled trial (RCT) methodology prior to a full scale trial. The overarching aim of this mixed-methods study is to develop a feasible research protocol for a RCT investigating the efficacy of a pain neurophysiology education informed pain management programme. In this feasibility study, participants with PP will be assessed before and after a PNE informed pain management program that they are due to receive as part of their usual care. In the week before the programme participants will attend Teesside University (TU) where they will complete a battery of outcome measures. A subsample of participants will also undergo a semi-structured interview. In the week following completion of their usual care PMP participants will once again attend TU where they will complete the same outcome measures and the same subsample of participants will undergo a second semi-structured interview. At this point participants will have completed the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2017

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 15, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

June 28, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2019

Completed
Last Updated

October 26, 2018

Status Verified

October 1, 2018

Enrollment Period

1.7 years

First QC Date

May 3, 2017

Last Update Submit

October 25, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Brief Pain Inventory (Short Form)

    Change from pre intervention (week 0) to post intervention (week 9)

Secondary Outcomes (27)

  • Centre of pressure

    Change from pre intervention (week 0) to post intervention (week 9)

  • Fifty-foot walk at fastest speed

    Change from pre intervention (week 0) to post intervention (week 9)

  • Repeated sit-to-stand

    Change from pre intervention (week 0) to post intervention (week 9)

  • The Pain Catastrophising Scale

    Change from pre intervention (week 0) to post intervention (week 9)

  • Neurophysiology of Pain Questionnaire

    Change from pre intervention (week 0) to post intervention (week 9)

  • +22 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with persistent musculoskeletal pain of greater than six months duration who have been referred to the pain management programme at James Cook University Hospital.

You may qualify if:

  • Have capacity to give informed consent
  • + years of age
  • Have had pain that has persisted for greater than six months
  • Have been referred to the pain management programme at James Cook University Hospital.

You may not qualify if:

  • Pain arising from a non-musculoskeletal origin such as cancer pain, visceral pain or post stroke pain
  • Have worsening neural signs
  • Anyone being treated by or who has been treated by the researcher (JW)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Teesside University

Middlesbrough, North Yorkshire, TS1 3BX, United Kingdom

Location

The Pain Clinic, South Tees Hospitals NHS Foundation Trust

Middlesbrough, North Yorkshire, TS4 3BW, United Kingdom

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

May 3, 2017

First Posted

May 15, 2017

Study Start

June 28, 2017

Primary Completion

March 8, 2019

Study Completion

March 8, 2019

Last Updated

October 26, 2018

Record last verified: 2018-10

Locations